Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872cba6f348bc925911dcb0bf3b0a87b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_431ed6f234e802dca5d57fa675838075 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
filingDate |
2002-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27fbd82a383131b49ac8f1ab63c51a1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af25316eb9e6b039ff06c7a79a50fe6d |
publicationDate |
2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-02067911-A1 |
titleOfInvention |
Pharmaceutical compositions comprising pravastatin for reducing ldl cholesterol levels |
abstract |
The instant invention provides methods and pharmaceutical compositions for reducing LDL cholesterol levels in mammals comprising the administration of a therapeutically effective amount of greater than 40 mg once per day of pravastatin, or a pharmaceutically acceptable salt or ester thereof, to a mammal in need of such treatment. |
priorityDate |
2001-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |